AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4
slide-5

Glimicer MV 2mg/500mg/0.2mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Retra Life Science Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Glimicer MV 2mg/500mg/0.2mg Tablet ER

Diabetic patients may benefit from using the extended-release combination medication, Glimicer MV 2mg/500mg/0.2mg Tablet ER, categorized as an anti-diabetic agent for adult type 2 diabetes mellitus management. This medication assists in regulating blood glucose. Administer this medicine with food, consistently at the same time daily for optimal effectiveness. Dosage adjustments are determined by your physician based on your blood sugar response. Continuous use is crucial, even with controlled blood sugar, as discontinuation without medical consultation can elevate blood glucose levels, potentially causing kidney issues, vision loss, neuropathy, and limb complications. This medication forms part of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as recommended by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect. Learn to recognize symptoms like sweating, dizziness, headaches, and tremors, and know how to treat them. Regular meals and readily available glucose sources (e.g., sugary foods or juice) are essential. Alcohol consumption elevates hypoglycemia risk and should be minimized. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headaches, swelling (edema), blurry vision, bone fractures, and upper respiratory infections. Weight gain may occur. Contraindications include type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or breastfeeding individuals should seek medical advice before using this medication. Regular blood glucose monitoring and potential blood tests for blood cell counts and liver function are usually recommended by your physician.

Uses of Glimicer MV 2mg/500mg/0.2mg Tablet ER

Managing type 2 diabetes

Major Benefits of Glimicer MV 2mg/500mg/0.2mg Tablet ER:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glimicer MV 2mg/500mg/0.2mg Extended-Release tablets should be taken on an empty stomach.

Common Side effects of Glimicer MV 2mg/500mg/0.2mg Tablet ER:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Glimicer MV 2mg/500mg/0.2mg Tablet ER:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment schedule. Ingest the Glimicer MV 2mg/500mg/0.2mg Extended-Release tablet whole; do not chew, crush, or fracture it. Consumption should occur on an empty stomach.

How Glimicer MV 2mg/500mg/0.2mg Tablet ER works:

Extended-release Glimicer MV tablets (2mg/500mg/0.2mg) contain a triple-action antidiabetic formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining alcohol and Glimicer MV 2mg/500mg/0.2mg Tablet ER is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Glimicer MV 2mg/500mg/0.2mg tablet might pose risks during pregnancy. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing this medication. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Glimicer MV tablets (2mg/500mg/0.2mg) are likely not safe for use while breastfeeding. Available human data indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyUNSAFE

Extended-release Glimicer MV tablets (2mg/500mg/0.2mg) are likely unsafe for individuals with kidney impairment and should be omitted. Medical advice is necessary. Furthermore, this medication is unsuitable for patients exhibiting severe kidney dysfunction.

LiverLiverCAUTION

Patients with liver impairment should use Glimicer MV 2mg/500mg/0.2mg Extended-Release tablets cautiously. Dosage modifications may be necessary. Physician consultation is advised. For those with mild to moderate liver disease, a low initial dose is typically recommended; however, its use is contraindicated in cases of severe hepatic dysfunction.

What if you forget to take Glimicer MV 2mg/500mg/0.2mg Tablet ER :

Should you forget to take your Glimicer MV 2mg/500mg/0.2mg Extended-Release tablet, administer it immediately upon remembering. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take more than the prescribed dose.

Facts to Know About Glimicer MV 2mg/500mg/0.2mg Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimicer MV 2mg/500mg/0.2mg Tablet ER

Glimicer MV 2mg/500mg/0.2mg Extended-Release Tablets combine glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus in adults. This combination therapy improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas; metformin reduces liver glucose production and enhances insulin sensitivity; and voglibose, an alpha-glucosidase inhibitor, lowers postprandial glucose levels. This medication is not suitable for type 1 diabetes.
Glimicer MV 2mg/500mg/0.2mg ER tablets may cause common side effects such as hypoglycemia, nausea, diarrhea, taste changes, flatulence, stomach pain, headache, rash, and respiratory infections.
Glimicer MV 2mg/500mg/0.2mg Tablet ER is contraindicated in patients allergic to its components or excipients, those with moderate-to-severe kidney disease, inflammatory bowel disease, colonic ulcerations, and underlying metabolic acidosis (including diabetic ketoacidosis).
Consuming alcohol with Glimicer MV 2mg/500mg/0.2mg Tablet ER is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glimicer MV 2mg/500mg/0.2mg ER Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's kept out of reach of children, pets, and others.
Glimicer MV 2mg/500mg/0.2...
132
MRP 161
17% off